| 英文名称 |
中文名称 |
CAS号 |
操作 |
| 2,4-Dichlorotoluene |
2,4-二氯甲苯 |
95-73-8 |
详细
|
| 2,4-Dichlorobenzoyl chloride |
2,4-二氯苯甲酰氯 |
89-75-8 |
详细
|
| Pyropheophorbide a |
焦脱镁叶绿酸-ALPHA |
24533-72-0 |
详细
|
| Purpurin 18 |
红紫素 18 |
25465-77-4 |
详细
|
| Protoporphyrin IX dimethyl ester |
原卟啉 IX 二甲酯 |
5522-66-7 |
详细
|
| meso-Tetra(4-carboxyphenyl)porphine |
中-四(4-羧基苯基)卟吩 |
14609-54-2 |
详细
|
| 5,10,15,20-Tetraphenylporphin |
四苯基卟啉 |
917-23-7 |
详细
|
| Deuteroporphyrin IX dihydrochloride |
二(丙酸甲基)卟啉二盐酸盐 |
68929-05-5 |
详细
|
| Vacuolin-1 |
3-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone |
351986-85-1 |
详细
|
| iFSP1 |
1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile |
150651-39-1 |
详细
|
| Tubulin inhibitor 6 |
Tubulin inhibitor 6 |
105925-39-1 |
详细
|
| MSAB |
3-(4-甲基苯基磺酰胺基)苯甲酸甲酯 |
173436-66-3 |
详细
|
| CB-103 |
6-[4-(叔丁基)苯氧基]吡啶-3-胺 |
218457-67-1 |
详细
|
| CFTRinh-172 |
CFTRinh-172 |
307510-92-5 |
详细
|
| CU-CPT-9B |
CU-CPT-9B, CPD2004 |
2165340-32-7 |
详细
|
| MSA-2 |
MSA-2 |
129425-81-6 |
详细
|
| KU-55933 |
2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 |
587871-26-9 |
详细
|
| ASLAN003 |
ASLAN003 |
1035688-66-4 |
详细
|
| TRx0237(LMTX) |
TRX-0237 甲磺酸盐 |
1236208-20-0 |
详细
|
| SB-3CT |
SB-3CT |
292605-14-2 |
详细
|
| 2,3-BIS(BROMOMETHYL)QUINOXALINE 1,4-DIOXIDE |
1,4-二氧代-2,3-二溴甲基喹啉 |
18080-67-6 |
详细
|
| 2-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine |
2-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]-1,5-萘啶 |
446859-33-2 |
详细
|
| Protoporphyrin IX |
原卟啉 |
553-12-8 |
详细
|
| hemin |
氯化血红素 |
16009-13-5 |
详细
|
| Tazarotene |
他扎罗汀 |
118292-40-3 |
详细
|
| demethoxyyangonin |
去甲氧基醉椒素 |
15345-89-8 |
详细
|
| Mdivi-1 |
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮 |
338967-87-6 |
详细
|
| (Z)-4-Hydroxytamoxifen |
4-羟基三苯氧胺 |
68047-06-3 |
详细
|
| LY-2183240 |
5-([1,1'-联苯]-4-甲基)-N,N-二甲基-1H-四氮唑-1-甲酰胺 |
874902-19-9 |
详细
|
| 5-bromo-4-chloro-6-iodothieno[2,3-d]pyrimidine |
5-溴-4-氯-6-碘代噻吩并[2,3-D]嘧啶 |
1799610-89-1 |
详细
|
| (2R,3S)-Rel-2,3-bis(4-chlorophenyl)-2,3-butanediaMine |
(2R,3S)-REL-2,3-双(4-氯苯基)-2,3-丁二胺 |
939983-16-1 |
详细
|
| EC330 |
LIF抑制剂(EC330) |
2016795-77-8 |
详细
|
| ARS853 |
CS-2646 |
1629268-00-3 |
详细
|
| RG7112 |
[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮 |
939981-39-2 |
详细
|
| RSV604 |
CS-2092 |
676128-63-5 |
详细
|
| 2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol |
2-氯-3-甲基苯酚-4-频哪醇硼酸酯 |
1799612-10-4 |
详细
|
| 1-Bromo-2-methoxynapthalene |
1-溴-2-甲氧基萘 |
3401-47-6 |
详细
|
| 6-Hydroxynicotinic Acid |
6-羟基烟酸 |
5006-66-6 |
详细
|
| GSK690693 |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 |
937174-76-0 |
详细
|
| Inarigivir |
SB9000 |
475650-36-3 |
详细
|
| LR-90 |
2,2' - ((((((亚甲基双(2-氯-4,1-亚苯基))二(氮烷二基))二(羰基))双(氮烷二 |
245075-84-7 |
详细
|
| 1,4-Diazaspiro[5.5]undecan-3-one |
1,4-二氮杂螺[5.5]十一烷-3-酮 |
1547757-91-4 |
详细
|
| PF-06873600 |
PF-06873600 |
2185857-97-8 |
详细
|
| Rigosertibsodium |
瑞格色替钠 |
592542-60-4 |
详细
|
| Hydrazinium hydroxide |
4-(5-氯-2-乙氧基-4-氟苯甲酰氨基)-3,3-二甲基丁酸 |
1805818-57-8 |
详细
|
| DO-264 |
DO264 |
2301866-59-9 |
详细
|
| 2,4-Dichlorobenzaldehyde |
2,4-二氯苯甲醛 |
874-42-0 |
详细
|
| 4-chlorobenzaldehyde |
对氯苯甲醛 |
104-88-1 |
详细
|
| Prohexadionecalcium |
调环酸钙 |
127277-53-6 |
详细
|
| DEPC |
1,2-二芥酰-SN-甘油-3-磷酰胆碱 |
51779-95-4 |
详细
|
| DPPC |
二棕榈酸磷脂酰胆碱 |
63-89-8 |
详细
|
| 4-Bromo-2-methyl-2H-indazole |
4-溴-2-甲基-2H-吲唑 |
590417-93-9 |
详细
|
| 2,4-dichlorobenzoic acid |
2,4-二氯苯甲酸 |
50-84-0 |
详细
|
| (1R,4S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol |
(1R,4S)-1-甲基-4-(丙-1-烯-2-基)环己-2-烯醇 |
82769-01-5 |
详细
|
| β-Nicotinamide Mononucleotide |
β-烟酰胺单核苷酸 |
1094-61-7 |
详细
|
| 4-Chlorobenzaldehyde |
邻氯苯甲醛 |
89-98-5 |
详细
|
| CrizotinibHCl |
克里唑替尼盐酸 |
1415560-69-8 |
详细
|
| 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine |
5'-DMT-2'-TBDMS-BZ-RA |
81265-93-2 |
详细
|
| Budiodarone tartrate |
CS-2731 |
1346623-17-3 |
详细
|
| HM30181 (Mesylate) |
849675-87-2 |
849675-87-2 |
详细
|
| OTX015 |
OTX-015 |
202590-98-5 |
详细
|
| Riociguat |
利奥西呱 |
625115-55-1 |
详细
|
| Thiophen-2-carbonitril |
2-氰基噻吩 |
1003-31-2 |
详细
|
| 3-Thiophenecarbonitrile |
3-氰基噻吩 |
1641-09-4 |
详细
|
| HLM006474 |
CS-1224 |
353519-63-8 |
详细
|
| 2-Bromochlorobenzene |
2-溴氯苯 |
694-80-4 |
详细
|
| 3-Chlorobromobenzene |
间氯溴苯 |
108-37-2 |
详细
|
| 4-Brom-1,2-dichlorbenzol |
3,4-二氯溴苯 |
18282-59-2 |
详细
|
| 2,5-Dibromo-3-methylpyridine |
2,5-二溴-3-甲基吡啶 |
3430-18-0 |
详细
|
| 1,3-Diiodobenzene |
1,3-二碘苯 |
626-00-6 |
详细
|
| 2,5-Dibromo-6-Picoline |
2,5-二溴-6-甲基吡啶 |
39919-65-8 |
详细
|
| 2-Dimethylaminoisopropyl chloride hydrochloride |
N,N-二甲氨基-2-氯丙烷盐酸盐 |
4584-49-0 |
详细
|
| 1,4-Diiodobenzene |
1,4-二碘苯 |
624-38-4 |
详细
|
| 4-Iodoaniline |
对碘苯胺 |
540-37-4 |
详细
|
| ML216 |
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲 |
1430213-30-1 |
详细
|
| CPI-203 |
CPI-203 |
1446144-04-2 |
详细
|
| R configuration CPI169 |
R构型 CPI169 |
802175-07-0 |
详细
|
| Chlorin E6 |
二氢卟吩E6 |
19660-77-6 |
详细
|
| PT-2399 |
化合物PT2399 |
1672662-14-4 |
详细
|
| (Rac)-PT2399 |
(RAC)-PT2399 |
1672662-07-5 |
详细
|
| Umeclidinium Bromide |
芜地溴铵 |
869113-09-7 |
详细
|
| CPI-169 |
化合物CPI169 |
1450655-76-1 |
详细
|
| TH5487 |
TH 5487 |
2304947-71-3 |
详细
|
| AT13387 |
AT-13387 |
912999-49-6 |
详细
|
| Lerociclib |
G1T38 |
1628256-23-4 |
详细
|
| CH7057288 |
CH7057288 |
2095616-82-1 |
详细
|
| ONX-0914 |
ONX-0914 |
960374-59-8 |
详细
|
| Adavivint |
SM04690 |
1467093-03-3 |
详细
|
| Fostamatinib disodium |
福他替尼 |
901119-35-5 |
详细
|
| RBN-2397 |
RBN-2397 |
2381037-82-5 |
详细
|
| PT2385 |
CS-2108 |
1672665-49-4 |
详细
|
| G1T28 |
曲拉西利双盐酸盐 |
1977495-97-8 |
详细
|
| Mli-2 |
REL-3-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-4-嘧啶基]-5-[(1-甲基环丙基)氧基]-1H-吲唑 |
1627091-47-7 |
详细
|
| SX682 |
SX-682 |
1648843-04-2 |
详细
|
| MYF-01-37 |
MYF-01-37 |
2416417-65-5 |
详细
|
| (S)-2-Amino-N-((R)-1-(4-butyryl-4-phenylpiperidin-1-yl)-3-(4-methoxy-3-methylphenyl)-1-oxopropan-2-yl)-3-(1H-imidazol-4-yl)propanamide |
|
457893-91-3 |
详细
|
| 857370-29-9 |
|
857370-29-9 |
详细
|
| 4-(Methylthio)-1-butylamine |
4-(METHYLTHIO)-1-BUTYLAMINE |
55021-77-7 |
详细
|
| Erucin |
三芥子酸甘油酯 |
4430-36-8 |
详细
|
| ABBV-744 |
ABBV-744 |
2138861-99-9 |
详细
|
| TAK-063 |
1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮 |
1238697-26-1 |
详细
|
| AUT1 |
AUT1 |
1311136-84-1 |
详细
|